Partner With Us
We are actively pursuing opportunities for investment in promising biopharma start-ups. Join our network of investors.
Reach out
BioVentures
Moonshots That Land
Promising discoveries require more than strong science to reach patients. Across a network of 14 sites, the Parker Institute identifies and validates discoveries, develops intellectual property, and advances potential therapies toward clinical testing. Parker BioVentures further extends this work through company formation and investment, recruiting experienced leaders, providing early capital, and connecting companies with investors and partners. Proceeds from successful ventures are reinvested in Parker Institute research, supporting the next generation of discoveries.
The Network Effect
Our network provides fertile ground for brand-new biotech companies. At our bi-annual retreats, Parker Institute scientists, co-funders, and industry partners assemble and share what they’re working on. Each time, an extraordinary alchemy occurs: connections are made, partnerships are forged, and the seed for new companies is often planted.
Parker Builds
Scientific founders play an essential role in translating discoveries into new cancer therapies. Across our sites, Parker Institute investigators with entrepreneurial experience gain an edge in advancing promising technologies through company formation, clinical development, and commercialization. Many Parker Institute scientists have become repeat founders, applying scientific insight and company building experience across multiple ventures. Parker Institute BioVentures provides the leadership, capital and strategic support needed to move these companies forward, toward the goal of patient impact.
Our Portfolio
Our current portfolio of active or acquired companies comprises a mix of companies fully founded and built within the Parker Institute network, member-founded companies that often utilize Parker-supported innovations, and external companies operating at the forefront of immunotherapy.
